DocMeetings

Genetic testing is ubiquitous and increasingly available in healthcare. Genetic tests analyze genes, proteins, or combinations of DNA, RNA, and proteins, and are intended to provide patient-specific information to inform management, influence treatment decisions, and improve patient-oriented outcomes. Although within the field of oncology, many genetic tests utilize similar methods and platforms, tests with varied clinical applications require different approaches to assessing the evidence supporting their use.

During this 30-minute webinar, ECRI’s genetic counselor and the senior manager for scientific quality will share an inside look at how ECRI’s Genetic Test Assessment team approaches evidence assessment for cancer genetic tests intended to serve different clinical applications (e.g., diagnostic, prognostic, predictive, treatment monitoring, screening, risk assessment, companion diagnostics). The team will present case examples to further demonstrate why cancer genetic test assessment requires a nuanced approach.

Learning objectives

At the end of this webinar, attendees will be able to:

• Identify the different types of genetic tests used to guide management of patients with cancer
• Understand the need for nuanced approaches to assessing evidence for genetic tests serving different clinical applications
• Discuss how genetic testing evidence contributes to clinical decision-making in oncology